Stay updated on Preop Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page
- Check4 days agoChange DetectedLocations now include California; the California Locations subsection and the HHS Vulnerability Disclosure link were removed, and the revision was updated to v3.3.3.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.3.2 was added and revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedA government funding/operating-status notice banner was removed from the page. This change does not affect the study details or eligibility criteria.SummaryDifference0.4%

- Check54 days agoChange DetectedNo additions or deletions were detected on the Study Details page for NCT03844750; the content and layout appear unchanged.SummaryDifference0.5%

- Check83 days agoChange DetectedUpgrade to version v3.2.0 and add a government funding/operating-status notice for the NIH Clinical Center; remove the previous v3.1.0 reference.SummaryDifference2%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Preop Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Preop Pembrolizumab in Colorectal Cancer Clinical Trial page.